Skip to main content
. 2020 Jun 22:zxaa176. doi: 10.1093/ajhp/zxaa176

Table 3.

Documented Pharmacy Interventions in COVID-19 Cohort (n = 197)

Variable Value
Total interventions 1,572
Interventions per patient, mean (SD) 8 (9)
Interventions per patient-day, mean 1
Intervention types, No. (%)a
 Regimen simplification 250 (15.9)
 Timing and dosing adjustments 242 (15.4)
 Antimicrobials and COVID-19 treatment 239 (15.2)
 Sedation and neuromuscular blockers 226 (14.4)
 Other 198 (12.6)
 Prophylaxis 155 (9.9)
 Electrolytes 57 (3.6)
 Fluid management 50 (3.2)
 Adverse drug event avoidance and management 43 (2.7)
 Drug-drug interactions 32 (2)
 Respiratory medications 32 (2)
 Intravenous drips 29 (1.8)
 Experimental agent trial enrollment 19 (1.2)
Interventions per patient receiving therapy, mean (SD)
 Sedation and neuromuscular blockers 3.7 (4.7)
 Antimicrobials and COVID-19 treatment 1.5 (2.2)
 Respiratory medications 1 (0.9)
 Electrolytes 0.3 (0.7)

Abbreviations: DOT, days of therapy.

aData are number (percentage) of total interventions.